BA
PTX

BlackRock Advisors’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

BlackRock Advisors’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1K Hold
763
– – ﹤0.01% 3699
2016
Q3 		$5K Hold
763
– – ﹤0.01% 3652
2016
Q2 		$3K Sell
763
-24,105
-97% -$157K ﹤0.01% 3710
2016
Q1 		$261K Buy
24,868
+12,663
+104% +$252K ﹤0.01% 2426
2015
Q4 		$360K Buy
12,205
+217
+2% +$6.56K ﹤0.01% 2257
2015
Q3 		$379K Buy
11,988
+9,354
+355% +$448K ﹤0.01% 2373
2015
Q2 		$156K Buy
2,634
+656
+33% +$46.3K ﹤0.01% 2943
2015
Q1 		$211K Buy
1,978
+305
+18% +$29.1K ﹤0.01% 2646
2014
Q4 		$157K Sell
1,673
-101
-6% -$9.63K ﹤0.01% 2790
2014
Q3 		$136K Sell
1,774
-41
-2% -$3.23K ﹤0.01% 2841
2014
Q2 		$163K Buy
1,815
+431
+31% +$26.4K ﹤0.01% 2759
2014
Q1 		$74K Buy
1,384
+94
+7% +$3.1K ﹤0.01% 3152
2013
Q4 		$33K Buy
1,290
+187
+17% +$4.45K ﹤0.01% 3307
2013
Q3 		$30K Buy
1,103
+54
+5% +$1.74K ﹤0.01% 3263
2013
Q2 		$38K Buy
+1,049
New +$39.3K ﹤0.01% 3211

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock Advisors's PTX Position: Q4 2016 in Review

BlackRock Advisors held its Pernix Therapeutics Holdings, Inc. (PTX) position steady in Q4 2016 at 763 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #3699.

BlackRock Advisors first reported a position in PTX in Q2 2013 and has held it in 15 quarters since. The position peaked at $379K in Q3 2015. 34 funds tracked by Wall St. Rank hold PTX as of Q4 2016.

  • BlackRock Advisors held 763 shares of Pernix Therapeutics Holdings, Inc. worth $1K as of Q4 2016.
  • BlackRock Advisors left its Pernix Therapeutics Holdings, Inc. share count unchanged in Q4 2016.
  • Pernix Therapeutics Holdings, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3699 holding.
  • BlackRock Advisors first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Pernix Therapeutics Holdings, Inc. position peaked at $379K in Q3 2015.
  • 34 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.